160 related articles for article (PubMed ID: 25746071)
1. [A case of neurologic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome with a novel mitochondrial mutation m.8729 G>A].
Miyawaki T; Koto S; Ishihara H; Goto Y; Nishino I; Kanda F; Toda T
Rinsho Shinkeigaku; 2015; 55(2):91-5. PubMed ID: 25746071
[TBL] [Abstract][Full Text] [Related]
2. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
[TBL] [Abstract][Full Text] [Related]
3. A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome.
Mordel P; Schaeffer S; Dupas Q; Laville MA; Gérard M; Chapon F; Allouche S
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):133-137. PubMed ID: 29054413
[TBL] [Abstract][Full Text] [Related]
4. Isolated late-onset cone-rod dystrophy revealing a familial neurogenic muscle weakness, ataxia, and retinitis pigmentosa syndrome with the T8993G mitochondrial mutation.
Porto FB; Mack G; Sterboul MJ; Lewin P; Flament J; Sahel J; Dollfus H
Am J Ophthalmol; 2001 Dec; 132(6):935-7. PubMed ID: 11730668
[TBL] [Abstract][Full Text] [Related]
5. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
Goto Y
Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
[No Abstract] [Full Text] [Related]
6. A novel mitochondrial mutation m.8989G>C associated with neuropathy, ataxia, retinitis pigmentosa - the NARP syndrome.
Duno M; Wibrand F; Baggesen K; Rosenberg T; Kjaer N; Frederiksen AL
Gene; 2013 Feb; 515(2):372-5. PubMed ID: 23266623
[TBL] [Abstract][Full Text] [Related]
7. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
Parfait B; de Lonlay P; von Kleist-Retzow JC; Cormier-Daire V; Chrétien D; Rötig A; Rabier D; Saudubray JM; Rustin P; Munnich A
Eur J Pediatr; 1999 Jan; 158(1):55-8. PubMed ID: 9950309
[TBL] [Abstract][Full Text] [Related]
8. Renal Involvement in Neuropathy, Ataxia, Retinitis Pigmentosa (NARP) Syndrome: A Case Report.
Lemoine S; Panaye M; Rabeyrin M; Errazuriz-Cerda E; Mousson de Camaret B; Petiot P; Juillard L; Guebre-Egziabher F
Am J Kidney Dis; 2018 May; 71(5):754-757. PubMed ID: 29224958
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous patterns of tissue injury in NARP syndrome.
Gelfand JM; Duncan JL; Racine CA; Gillum LA; Chin CT; Zhang Y; Zhang Q; Wong LJ; Roorda A; Green AJ
J Neurol; 2011 Mar; 258(3):440-8. PubMed ID: 20953793
[TBL] [Abstract][Full Text] [Related]
10. Identification and biochemical characterization of the novel mutation m.8839G>C in the mitochondrial ATP6 gene associated with NARP syndrome.
Blanco-Grau A; Bonaventura-Ibars I; Coll-Cantí J; Melià MJ; Martinez R; Martínez-Gallo M; Andreu AL; Pinós T; García-Arumí E
Genes Brain Behav; 2013 Nov; 12(8):812-20. PubMed ID: 24118886
[TBL] [Abstract][Full Text] [Related]
11. Novel genetic and neuropathological insights in neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP).
Claeys KG; Abicht A; Häusler M; Kleinle S; Wiesmann M; Schulz JB; Horvath R; Weis J
Muscle Nerve; 2016 Aug; 54(2):328-33. PubMed ID: 27015314
[TBL] [Abstract][Full Text] [Related]
12. [NARP syndrome--a less known mitochondrial disease].
Kuusisto H; Simola KO; Keränen T
Duodecim; 2003; 119(16):1563-6. PubMed ID: 14535029
[No Abstract] [Full Text] [Related]
13. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
[TBL] [Abstract][Full Text] [Related]
14. NARP mutation and mtDNA depletion trigger mitochondrial biogenesis which can be modulated by selenite supplementation.
Wojewoda M; Duszyński J; Szczepanowska J
Int J Biochem Cell Biol; 2011 Aug; 43(8):1178-86. PubMed ID: 21550418
[TBL] [Abstract][Full Text] [Related]
15. Retinopathy of NARP syndrome.
Kerrison JB; Biousse V; Newman NJ
Arch Ophthalmol; 2000 Feb; 118(2):298-9. PubMed ID: 10676807
[No Abstract] [Full Text] [Related]
16. High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes.
Tsao CY; Mendell JR; Bartholomew D
J Child Neurol; 2001 Jul; 16(7):533-5. PubMed ID: 11453454
[TBL] [Abstract][Full Text] [Related]
17. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
[TBL] [Abstract][Full Text] [Related]
18. Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome.
Finsterer J
J Clin Neuromuscul Dis; 2023 Mar; 24(3):140-146. PubMed ID: 36809201
[TBL] [Abstract][Full Text] [Related]
19. NARP syndrome and adult-onset generalised seizures.
Keränen T; Kuusisto H
Epileptic Disord; 2006 Sep; 8(3):200-3. PubMed ID: 16987741
[TBL] [Abstract][Full Text] [Related]
20. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA.
Geromel V; Kadhom N; Cebalos-Picot I; Ouari O; Polidori A; Munnich A; Rötig A; Rustin P
Hum Mol Genet; 2001 May; 10(11):1221-8. PubMed ID: 11371515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
